{{PBB|geneid=5371}}
'''早幼粒细胞白血病蛋白'''是指可能的转录因子可能的转录因子（{{lang-en|'''Probable transcription factor PML'''}}），是一个由人类[[基因|基因]] ''PML'' 编码的抑癌蛋白。

== 功能 ==
== 互作 ==

早幼粒细胞白血病蛋白可与下列蛋白質发生[[蛋白質交互作用|交互作用]]：
{{div col|colwidth=20em}}
* [[ANKRD2|ANKRD2]],<ref name = pmid15136035>{{vcite2 journal | vauthors = Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, Valle G, Faulkner G | title = The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle | journal = J. Mol. Biol. | volume = 339 | issue = 2 | pages = 313-25 | date = May 2004 | pmid = 15136035 | doi = 10.1016/j.jmb.2004.03.071 }}</ref> 
* [[CREB-binding_protein|CREB-binding protein]],<ref name = pmid10610177/><ref name = pmid12622724>{{vcite2 journal | vauthors = Matsuzaki K, Minami T, Tojo M, Honda Y, Saitoh N, Nagahiro S, Saya H, Nakao M | title = PML-nuclear bodies are involved in cellular serum response | journal = Genes Cells | volume = 8 | issue = 3 | pages = 275-86 | date = Mar 2003 | pmid = 12622724 | doi =  }}</ref><ref name = pmid10077561>{{vcite2 journal | vauthors = Doucas V, Tini M, Egan DA, Evans RM | title = Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 96 | issue = 6 | pages = 2627-32 | date = Mar 1999 | pmid = 10077561 | pmc = 15819 | doi =  }}</ref> 
* [[Cyclin_T1|Cyclin T1]],<ref name = pmid12727882>{{vcite2 journal | vauthors = Marcello A, Ferrari A, Pellegrini V, Pegoraro G, Lusic M, Beltram F, Giacca M | title = Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein | journal = EMBO J. | volume = 22 | issue = 9 | pages = 2156-66 | date = May 2003 | pmid = 12727882 | pmc = 156077 | doi = 10.1093/emboj/cdg205 }}</ref> 
* [[Death_associated_protein_6|Death associated protein 6]],<ref name = pmid10525530>{{vcite2 journal | vauthors = Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, Maul GG | title = PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1 | journal = J. Cell Biol. | volume = 147 | issue = 2 | pages = 221-34 | date = Oct 1999 | pmid = 10525530 | pmc = 2174231 | doi =  }}</ref><ref name = pmid10669754>{{vcite2 journal | vauthors = Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ, Chen JD | title = Sequestration and inhibition of Daxx-mediated transcriptional repression by PML | journal = Mol. Cell. Biol. | volume = 20 | issue = 5 | pages = 1784-96 | date = Mar 2000 | pmid = 10669754 | pmc = 85360 | doi =  }}</ref><ref name = pmid11244500>{{vcite2 journal | vauthors = Lehembre F, Müller S, Pandolfi PP, Dejean A | title = Regulation of Pax3 transcriptional activity by SUMO-1-modified PML | journal = Oncogene | volume = 20 | issue = 1 | pages = 1-9 | date = Jan 2001 | pmid = 11244500 | doi = 10.1038/sj.onc.1204063 }}</ref><ref name = pmid10684855>{{vcite2 journal | vauthors = Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP | title = Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis | journal = J. Exp. Med. | volume = 191 | issue = 4 | pages = 631-40 | date = Feb 2000 | pmid = 10684855 | pmc = 2195846 | doi =  }}</ref> 
* [[GATA2|GATA2]],<ref name = pmid10938104>{{vcite2 journal | vauthors = Tsuzuki S, Towatari M, Saito H, Enver T | title = Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein | journal = Mol. Cell. Biol. | volume = 20 | issue = 17 | pages = 6276-86 | date = Sep 2000 | pmid = 10938104 | pmc = 86102 | doi =  }}</ref> 
* [[HDAC1|HDAC1]],<ref name = pmid11430826>{{vcite2 journal | vauthors = Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Shinagawa T, Ichikawa-Iwata E, Zhong S, Pandolfi PP, Ishii S | title = Role of PML and PML-RARalpha in Mad-mediated transcriptional repression | journal = Mol. Cell | volume = 7 | issue = 6 | pages = 1233-43 | date = Jun 2001 | pmid = 11430826 | doi =  }}</ref><ref name = pmid11259576>{{vcite2 journal | vauthors = Wu WS, Vallian S, Seto E, Yang WM, Edmondson D, Roth S, Chang KS | title = The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases | journal = Mol. Cell. Biol. | volume = 21 | issue = 7 | pages = 2259-68 | date = Apr 2001 | pmid = 11259576 | pmc = 86860 | doi = 10.1128/MCB.21.7.2259-2268.2001 }}</ref> 
* [[HDAC3|HDAC3]],<ref name = pmid11259576/> 
* [[HHEX|HHEX]],<ref name = pmid10597310>{{vcite2 journal | vauthors = Topcu Z, Mack DL, Hromas RA, Borden KL | title = The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control | journal = Oncogene | volume = 18 | issue = 50 | pages = 7091-100 | date = Nov 1999 | pmid = 10597310 | doi = 10.1038/sj.onc.1203201 }}</ref> 
* [[MAPK11|MAPK11]],<ref name = pmid15273249>{{vcite2 journal | vauthors = Shin J, Park B, Cho S, Lee S, Kim Y, Lee SO, Cho K, Lee S, Jin BS, Ahn JH, Choi EJ, Ahn K | title = Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase | journal = J. Biol. Chem. | volume = 279 | issue = 39 | pages = 40994-1003 | date = Sep 2004 | pmid = 15273249 | doi = 10.1074/jbc.M407369200 }}</ref> 
* [[MYB|MYB]],<ref name = pmid15194430>{{vcite2 journal | vauthors = Dahle Ø, Bakke O, Gabrielsen OS | title = c-Myb associates with PML in nuclear bodies in hematopoietic cells | journal = Exp. Cell Res. | volume = 297 | issue = 1 | pages = 118-26 | date = Jul 2004 | pmid = 15194430 | doi = 10.1016/j.yexcr.2004.03.014 }}</ref> 
* [[Mdm2|Mdm2]],<ref name = pmid12915590/><ref name = pmid15195100/><ref name = pmid14507915>{{vcite2 journal | vauthors = Zhu H, Wu L, Maki CG | title = MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53 | journal = J. Biol. Chem. | volume = 278 | issue = 49 | pages = 49286-92 | date = Dec 2003 | pmid = 14507915 | doi = 10.1074/jbc.M308302200 }}</ref><ref name = pmid12759344>{{vcite2 journal | vauthors = Wei X, Yu ZK, Ramalingam A, Grossman SR, Yu JH, Bloch DB, Maki CG | title = Physical and functional interactions between PML and MDM2 | journal = J. Biol. Chem. | volume = 278 | issue = 31 | pages = 29288-97 | date = Aug 2003 | pmid = 12759344 | doi = 10.1074/jbc.M212215200 }}</ref> 
* [[Nerve_Growth_factor_IB|Nerve Growth factor IB]],<ref name = pmid12032831>{{vcite2 journal | vauthors = Wu WS, Xu ZX, Ran R, Meng F, Chang KS | title = Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions | journal = Oncogene | volume = 21 | issue = 24 | pages = 3925-33 | date = May 2002 | pmid = 12032831 | doi = 10.1038/sj.onc.1205491 }}</ref> 
* [[Nuclear_receptor_co-repressor_1|Nuclear receptor co-repressor 1]],<ref name = pmid11430826/> 
* [[Nuclear_receptor_co-repressor_2|Nuclear receptor co-repressor 2]],<ref name = pmid11430826/><ref name = pmid11585900>{{vcite2 journal | vauthors = Hong SH, Yang Z, Privalsky ML | title = Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia | journal = Mol. Cell. Biol. | volume = 21 | issue = 21 | pages = 7172-82 | date = Nov 2001 | pmid = 11585900 | pmc = 99892 | doi = 10.1128/MCB.21.21.7172-7182.2001 }}</ref> 
* [[P53|P53]],<ref name = pmid12915590>{{vcite2 journal | vauthors = Kurki S, Latonen L, Laiho M | title = Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization | journal = J. Cell. Sci. | volume = 116 | issue = Pt 19 | pages = 3917-25 | date = Oct 2003 | pmid = 12915590 | doi = 10.1242/jcs.00714 }}</ref><ref name = pmid11080164>{{vcite2 journal | vauthors = Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C, Del Sal G | title = Regulation of p53 activity in nuclear bodies by a specific PML isoform | journal = EMBO J. | volume = 19 | issue = 22 | pages = 6185-95 | date = Nov 2000 | pmid = 11080164 | pmc = 305840 | doi = 10.1093/emboj/19.22.6185 }}</ref><ref name = pmid11025664>{{vcite2 journal | vauthors = Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, Pandolfi PP | title = The function of PML in p53-dependent apoptosis | journal = Nat. Cell Biol. | volume = 2 | issue = 10 | pages = 730-6 | date = Oct 2000 | pmid = 11025664 | doi = 10.1038/35036365 }}</ref> 
* [[RPL11|RPL11]],<ref name = pmid15195100>{{vcite2 journal | vauthors = Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP | title = PML regulates p53 stability by sequestering Mdm2 to the nucleolus | journal = Nat. Cell Biol. | volume = 6 | issue = 7 | pages = 665-72 | date = Jul 2004 | pmid = 15195100 | doi = 10.1038/ncb1147 }}</ref> 
* [[视网膜母细胞瘤蛋白|视网膜母细胞瘤蛋白]]<ref name = pmid9448006>{{vcite2 journal | vauthors = Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K, Pelicci PG | title = The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein | journal = Mol. Cell. Biol. | volume = 18 | issue = 2 | pages = 1084-93 | date = Feb 1998 | pmid = 9448006 | pmc = 108821 | doi =  }}</ref> 
* [[视黄酸受体α|视黄酸受体α]],<ref name = pmid10610177>{{vcite2 journal | vauthors = Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP | title = A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins | journal = Nat. Genet. | volume = 23 | issue = 3 | pages = 287-95 | date = Nov 1999 | pmid = 10610177 | doi = 10.1038/15463 }}</ref> 
* [[SIN3A|SIN3A]],<ref name = pmid11430826/> 
* [[SKI_protein|SKI protein]],<ref name = pmid11430826/> 
* [[STAT3|STAT3]],<ref name = pmid12506013>{{vcite2 journal | vauthors = Kawasaki A, Matsumura I, Kataoka Y, Takigawa E, Nakajima K, Kanakura Y | title = Opposing effects of PML and PML/RAR alpha on STAT3 activity | journal = Blood | volume = 101 | issue = 9 | pages = 3668-73 | date = May 2003 | pmid = 12506013 | doi = 10.1182/blood-2002-08-2474 }}</ref> 
* [[Serum_response_factor|Serum response factor]]<ref name = pmid12622724/> and 
* [[Small_ubiquitin-related_modifier_1|Small ubiquitin-related modifier 1]],<ref name = pmid11948183>{{vcite2 journal | vauthors = Lin DY, Shih HM | title = Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration | journal = J. Biol. Chem. | volume = 277 | issue = 28 | pages = 25446-56 | date = Jul 2002 | pmid = 11948183 | doi = 10.1074/jbc.M200633200 }}</ref><ref name = pmid9452416>{{vcite2 journal | vauthors = Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, Yeh ET | title = Covalent modification of PML by the sentrin family of ubiquitin-like proteins | journal = J. Biol. Chem. | volume = 273 | issue = 6 | pages = 3117-20 | date = Feb 1998 | pmid = 9452416 | doi =  }}</ref>
* [[Sp1_transcription_factor|Sp1 transcription factor]],<ref name = pmid9819401>{{vcite2 journal | vauthors = Vallian S, Chin KV, Chang KS | title = The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter | journal = Mol. Cell. Biol. | volume = 18 | issue = 12 | pages = 7147-56 | date = Dec 1998 | pmid = 9819401 | pmc = 109296 | doi =  }}</ref> 
* [[TOPBP1|TOPBP1]],<ref name = pmid12773567>{{vcite2 journal | vauthors = Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS | title = PML colocalizes with and stabilizes the DNA damage response protein TopBP1 | journal = Mol. Cell. Biol. | volume = 23 | issue = 12 | pages = 4247-56 | date = Jun 2003 | pmid = 12773567 | pmc = 156140 | doi =  }}</ref> 
* [[Thymine-DNA_glycosylase|Thymine-DNA glycosylase]],<ref name = pmid15569683>{{vcite2 journal | vauthors = Takahashi H, Hatakeyama S, Saitoh H, Nakayama KI | title = Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein | journal = J. Biol. Chem. | volume = 280 | issue = 7 | pages = 5611-21 | date = Feb 2005 | pmid = 15569683 | doi = 10.1074/jbc.M408130200 }}</ref>  and
* [[Zinc_finger_and_BTB_domain-containing_protein_16|Zinc finger and BTB domain-containing protein 16]].<ref name = pmid9294197>{{vcite2 journal | vauthors = Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de Thé H, Zelent A | title = Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 94 | issue = 19 | pages = 10255-60 | date = Sep 1997 | pmid = 9294197 | pmc = 23349 | doi =  }}</ref> 
{{Div col end}}

== 参见 ==
* [[RING_finger_domain|RING finger domain]]

{{-}}

== 参考文献==
{{reflist|35em}}

== 延伸阅读 ==
{{refbegin|35em}}
* {{vcite2 journal | vauthors = Zhong S, Salomoni P, Pandolfi PP | title = The transcriptional role of PML and the nuclear body | journal = Nat. Cell Biol. | volume = 2 | issue = 5 | pages = E85–90 | year = 2000 | pmid = 10806494 | doi = 10.1038/35010583 }}
* {{vcite2 journal | vauthors = Jensen K, Shiels C, Freemont PS | title = PML protein isoforms and the RBCC/TRIM motif | journal = Oncogene | volume = 20 | issue = 49 | pages = 7223–33 | year = 2001 | pmid = 11704850 | doi = 10.1038/sj.onc.1204765 }}
* {{vcite2 journal | vauthors = Pearson M, Pelicci PG | title = PML interaction with p53 and its role in apoptosis and replicative senescence | journal = Oncogene | volume = 20 | issue = 49 | pages = 7250–6 | year = 2001 | pmid = 11704853 | doi = 10.1038/sj.onc.1204856 }}
* {{vcite2 journal | vauthors = Salomoni P, Pandolfi PP | title = The role of PML in tumor suppression | journal = Cell | volume = 108 | issue = 2 | pages = 165–70 | year = 2002 | pmid = 11832207 | doi = 10.1016/S0092-8674(02)00626-8 }}
* {{vcite2 journal | vauthors = Combes R, Balls M, Bansil L, Barratt M, Bell D, Botham P, Broadhead C, Clothier R, George E, Fentem J, Jackson M, Indans I, Loizu G, Navaratnam V, Pentreath V, Phillips B, Stemplewski H, Stewart J | title = An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the second FRAME Toxicity Committee (1991) | journal = Alternatives to laboratory animals : ATLA | volume = 30 | issue = 4 | pages = 365–406 | year = 2002 | pmid = 12234245 | doi =  }}
* {{vcite2 journal | vauthors = Bernardi R, Pandolfi PP | title = Role of PML and the PML-nuclear body in the control of programmed cell death | journal = Oncogene | volume = 22 | issue = 56 | pages = 9048–57 | year = 2004 | pmid = 14663483 | doi = 10.1038/sj.onc.1207106 }}
* {{vcite2 journal | vauthors = Beez S, Demmer P, Puccetti E | title = Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides | journal = PLOS ONE | volume = 7 | issue = 11 | pages = e48636 | year = 2012 | pmid = 23152790 | pmc = 3494703 | doi = 10.1371/journal.pone.0048636 }}
{{refend}}

== 外部链接 ==
* {{MeshName|PML+protein,+human}}

{{PDB Gallery|geneid=5371}}